Q2 2024 · 13F-HR
Ally Bridge Group (NY) LLCholdings as filed
Filed 2024-08-14 · accession 0000950123-24-008408
$167.9M
Reported value
25
Positions
2024-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $11.7M | 6.96% | 286,162 | Common | SOLE |
| 803607100 | SRPT | SAREPTA THERAPEUTICS INC | $11.6M | 6.92% | 73,500 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $11.6M | 6.91% | 2,736,663 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $10.3M | 6.16% | 174,844 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $8.6M | 5.15% | 129,000 | Common | SOLE |
| 52490G102 | LEGN | LEGEND BIOTECH CORP | $8.6M | 5.15% | 195,000 | Common | SOLE |
| 022307102 | ALMS | ALUMIS INC | $8.2M | 4.90% | 618,750 | Common | SOLE |
| 09627Y109 | 2655787D | BLUEPRINT MEDICINES CORP | $8.2M | 4.86% | 75,638 | Common | SOLE |
| 254604101 | IRON | DISC MEDICINE INC | $7.5M | 4.47% | 166,500 | Common | SOLE |
| 23954D109 | DAWNGBX | DAY ONE BIOPHARMACEUTICALS I | $7.4M | 4.40% | 536,095 | Common | SOLE |
| 60255C885 | BRD1EUR | MIND MEDICINE MINDMED INC | $7.0M | 4.15% | 965,426 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $6.6M | 3.93% | 169,369 | Common | SOLE |
| 74006W207 | PRAX | PRAXIS PRECISION MEDICINES I | $6.3M | 3.78% | 153,379 | Common | SOLE |
| 50127T109 | KURA | KURA ONCOLOGY INC | $6.3M | 3.76% | 306,762 | Common | SOLE |
| G29687103 | AVDL | AVADEL PHARMACEUTICALS PLC | $6.0M | 3.60% | 430,245 | Common | SOLE |
| 54300N103 | — | LONGBOARD PHARMACEUTICALS IN | $5.9M | 3.53% | 218,981 | Common | SOLE |
| 156944100 | CGON | CG ONCOLOGY INC | $5.5M | 3.29% | 174,876 | Common | SOLE |
| 471871202 | JSPR | JASPER THERAPEUTICS INC | $5.0M | 2.96% | 218,614 | Common | SOLE |
| 89532M101 | TRVI | TREVI THERAPEUTICS INC | $4.4M | 2.62% | 1,474,926 | Common | SOLE |
| 90240B106 | TYRA | TYRA BIOSCIENCES INC | $4.2M | 2.52% | 264,660 | Common | SOLE |
| 46489V302 | CATX | PERSPECTIVE THERAPEUTICS INC | $4.0M | 2.35% | 396,242 | Common | SOLE |
| 09203E105 | BDTX | BLACK DIAMOND THERAPEUTICS I | $3.9M | 2.32% | 835,000 | Common | SOLE |
| 21077P108 | CNTX | CONTEXT THERAPEUTICS INC | $3.8M | 2.25% | 1,886,232 | Common | SOLE |
| 28658R106 | CLYM | ELIEM THERAPEUTICS INC | $3.6M | 2.12% | 500,000 | Common | SOLE |
| 74346M406 | PMNEUR | PROMIS NEUROSCIENCES INC | $1.6M | 0.95% | 1,059,582 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.